RNA
$32.16
Revenue | $2.97Mn |
Net Profits | $-102.26Mn |
Net Profit Margins | -3439.52% |
Avidity Biosciences Inc’s revenue jumped 35.57% since last year same period to $2.97Mn in the Q4 2024. On a quarterly growth basis, Avidity Biosciences Inc has generated 27.27% jump in its revenue since last 3-months.
Avidity Biosciences Inc’s net profit fell -69.18% since last year same period to $-102.26Mn in the Q4 2024. On a quarterly growth basis, Avidity Biosciences Inc has generated -27.19% fall in its net profits since last 3-months.
Avidity Biosciences Inc’s net profit margin fell -24.79% since last year same period to -3439.52% in the Q4 2024. On a quarterly growth basis, Avidity Biosciences Inc has generated 0.06% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.78 |
EPS Estimate Current Year | -0.78 |
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.78 - a -9.99% fall from last quarter’s estimates.
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.78.
Earning Per Share (EPS) | -0.8 |
Avidity Biosciences Inc’s earning per share (EPS) fell -1.27% since last year same period to -0.8 in the Q4 2024. This indicates that the Avidity Biosciences Inc has generated -1.27% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-09-30 | -0.71 | -0.65 | 8.45% |
2024-05-09 | -0.78 | -0.79 | -1.28% |
2025-02-27 | -0.78 | -0.8 | -2.45% |
2024-08-09 | -0.79 | -0.65 | 17.72% |